Xiangxue Pharmaceutical (300147) — Cash Flow Quality Index
Xiangxue Pharmaceutical (300147) has a Cash Flow Quality Index of 1.00x as of March 2023. Operating cash flow of CN¥8.28 Million exceeds net income of CN¥8.28 Million, indicating high earnings quality where cash backs reported profits. Explore how much of Xiangxue Pharmaceutical's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xiangxue Pharmaceutical Cash Flow Quality Index (2007–2020)
Historical Cash Flow Quality Index for Xiangxue Pharmaceutical across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300147 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Xiangxue Pharmaceutical (2007–2020)
Year-by-year earnings quality comparison for Xiangxue Pharmaceutical. For live market cap and the full company financial profile, see 300147 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.81x | CN¥257.18 Million | CN¥141.80 Million | ▲ +175.6% |
| 2019 | 0.66x | CN¥83.02 Million | CN¥126.13 Million | ▼ -36.5% |
| 2018 | 1.04x | CN¥91.24 Million | CN¥87.97 Million | ▲ +6.2% |
| 2017 | 0.98x | CN¥109.53 Million | CN¥112.13 Million | ▼ -51.9% |
| 2016 | 2.03x | CN¥198.48 Million | CN¥97.64 Million | ▲ +156.4% |
| 2015 | 0.79x | CN¥159.89 Million | CN¥201.65 Million | ▲ +3.7% |
| 2014 | 0.76x | CN¥165.58 Million | CN¥216.54 Million | ▼ -60.2% |
| 2013 | 1.92x | CN¥328.37 Million | CN¥171.09 Million | ▲ +76.2% |
| 2012 | 1.09x | CN¥118.91 Million | CN¥109.17 Million | ▲ +212.8% |
| 2011 | 0.35x | CN¥29.55 Million | CN¥84.88 Million | ▼ -42.2% |
| 2010 | 0.60x | CN¥45.47 Million | CN¥75.42 Million | ▼ -32.1% |
| 2009 | 0.89x | CN¥46.19 Million | CN¥52.06 Million | ▼ -40.6% |
| 2008 | 1.49x | CN¥55.72 Million | CN¥37.28 Million | ▼ -65.7% |
| 2007 | 4.35x | CN¥138.02 Million | CN¥31.69 Million | — |